JPRN-UMIN000050223招募中Unknown
Survey on the use of molecular targeted drugs for unresectable hepatocellular carcinoma. - Molecularly targeted drugs investigation for unresectable hepatocellular carcinoma.
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- Other
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who indicated their intention not to participate in the study
研究者
相似试验
招募中
不适用
Evaluation of the efficacy of molecular targeted drugs using biopsy samples in patients with advanced hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000039887Department of Gastroenterology and Metabolism, Hiroshima University Hospital50
招募中
不适用
The efficacy of molecular targeted therapy for unresectable hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000035136Kyoto University150
招募中
不适用
molecular based analysis and novel therapies development of chronic myelocytic leukemiachronic myelocytic leukemiaJPRN-UMIN000015409Keio University School of Medicine, Division of Hematology200
招募中
不适用
Combination of molecularly-targeted therapy with stereotactic body radiotherapy in hepatocellular carcinoma with major vascular invasioHepatocellular carcinoma with major vascular invasionJPRN-UMIN000030718Osaka International Cancer Institute20
招募中
1 期
An Imaging Phase I B Study Evaluating MK-0646 in Combination with Erlotinib for Patients with Advanced Non-Small Cell Lung CancerCTRI/2009/091/000139Merck & Co., Inc. One Merck DriveP.O. Box 100Whitehouse Station, NJ, 08889-0100, U.S.A.106